We have a responsibility to build upon the incredible progress that has been made in understanding the biology of disease and to develop life-changing medicines that allow for sustainable, equitable access. We’ve seen success in other industry’s market-based, disruptive solutions - now is the time for healthcare.


Alexis Borisy is a leading biotechnology entrepreneur and investor with more than 25 years of experience. He founded CombinatoRx in 1999 and is the co-founder of Foundation Medicine, Blueprint Medicines, Celsius Therapeutics and Relay Therapeutics. He’s also a founding investor for Editas Medicine, Magenta Therapeutics, Revolution Medicines and Thrive Earlier Detection. Alexis is the Chairman of the Board of Trustees of the Boston Museum of Science. He holds a master’s degree in chemistry and chemical biology from Harvard University and a B.S. in chemistry from the University of Chicago.

View All